Get started
Author

Robert E. Louie

Observed names: R E Louie, R. E. Louie, R. Louie, R.E. Louie, Robert E Louie, Robert Louie
OpenAlex ID: A5090295581
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single‐arm study
2006 · James R. Berenson, Ralph Boccia, et al. · British Journal of Haematology · 83
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
1984 · D R Milich, G G Leroux-Roels, et al. · The Journal of Experimental Medicine · 70
PDF
Inactivation of Hepatitis C Virus in Low pH Intravenous Immunoglobulin
1994 · Robert E. Louie, Cynthia J. Galloway, et al. · Biologicals · 41
Arsenic Trioxide in Multiple Myeloma
2002 · Kenneth C. Anderson, Lawrence H. Boise, et al. · The Cancer Journal · 38
Measurement of rabies antibody: comparison of the mouse neutralization test (MNT) with the rapid fluorescent focus inhibition test (RFFIT)
1975 · R.E. Louie, M.B. Dobkin, et al. · Journal of Biological Standardization · 34
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
1985 · D R Milich, R E Louie, et al. · The Journal of Immunology · 24
The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activity
1991 · Bishan S. Charak, Robert Louie, et al. · Journal of Antimicrobial Chemotherapy · 21
Antibody levels in reduced/alkylated intravenous immune globulin
1984 · Ralph H Rousell, Michael S Collins, et al. · The American Journal of Medicine · 17
Loss of Rubella Antibody from Immune Globulin Treated with Kaolin
1969 · V. J. Cabasso, R. E. Louie, et al. · Applied Microbiology · 9
PDF
Interference in Cortisone-Treated Hosts.
1953 · J. Fong, R. Louie · Experimental Biology and Medicine · 9
Treatment of Non-APL Acute Myelogenous Leukemia with Intravenous Arsenic Trioxide Plus Ascorbic Acid.
2005 · Dan Douer, Kristy Watkins, et al. · Blood · 7
Inactivation of viruses in therapeutic products derived from human plasma
1988 · Gautam Mitra, Milton B. Dobkin, et al. · The American Journal of Medicine · 7
Treatment of Non-APL Acute Myelogenous Leukemia with Intravenous Arsenic Trioxide Plus Ascorbic Acid.
2006 · Dan Douer, Kristy Watkins, et al. · Blood · 6
Preparation and Standardization of an Australia Antigen Antibody of Equine Origin
1971 · V. J. Cabasso, R. Nieman, et al. · Applied Microbiology · 6
Durable Molecular Remission in Two Acute Promyelocytic Leukemia (APL) Patients Treated with Arsenic Trioxide at First Molecular Relapse.
2005 · Dan Douer, Laleh Ramezani, et al. · Blood · 4
Treatment of Acute Myelogenous Leukemia (non-APL) with Intravenous Trisenox® (Arsenic Trioxide) and Ascorbic Acid: Preliminary Results.
2004 · Dan Douer, Kristy Watkins, et al. · Blood · 4
Detection of IgG-Associated Determinants in Reduced and Alkylated Preparations of Human IgG3 by Monoclonal Antibodies
1984 · Adrienne M. Brown, Michael L. Dumas, et al. · Vox Sanguinis · 4
Inactivation of Viruses with 1,10-Phenanthroline
2015 · K. J. Lembach, M. B. Dobkin, et al. · Current studies in hematology and blood transfusion · 3
Transmission of Hepatitis After the Administration of Intravenous Immunoglobulins
1993 · Ralph H. Rousell, Milton B. Dobkin, et al. · American Journal of Clinical Pathology · 3
Studies of the Interference Phenomenon in Mustard-Treated Hosts
1953 · Jacob Fong, Robert Louie, et al. · The Journal of Immunology · 3
Comparison of EBV-infectivity measured by EBNA-induction and immortalization of human B-cells
1992 · Myung-Sam Cho, Robert E. Louie · Biologicals · 2
Works count: 21
Citation count: 395
H-index: 9
I10-index: 8
Year
Topic
Type